These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 15791913)

  • 1. [Insulin resistance inpolycystic ovary syndrome].
    Castro-Acuña V; Martínez-Martínez L; del Carmen Cravioto M
    Rev Invest Clin; 2004; 56(6):763-72. PubMed ID: 15791913
    [No Abstract]   [Full Text] [Related]  

  • 2. [The direct effect of insulin on the ovary and the pathogenesis of the polycystic ovary syndrome].
    Presl J
    Cesk Gynekol; 1984 Mar; 49(2):124-5. PubMed ID: 6368015
    [No Abstract]   [Full Text] [Related]  

  • 3. Insulin resistance causes impaired vasodilation and hypofibrinolysis in young women with polycystic ovary syndrome.
    Carmassi F; De Negri F; Fioriti R; De Giorgi A; Giannarelli C; Fruzzetti F; Pedrinelli R; Dell'Omo G; Bersi C
    Thromb Res; 2005; 116(3):207-14. PubMed ID: 15935829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of insulin and hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome].
    Vasiljević M
    Srp Arh Celok Lek; 2000; 128(9-10):335-9. PubMed ID: 11255689
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin-sensitizing agents in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S28-9. PubMed ID: 16798283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Papavassiliou AG
    Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Polycystic ovary syndrome and insulin resistance].
    Puder J; Pralong F
    Rev Med Suisse; 2009 Apr; 5(198):779-82. PubMed ID: 19418980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal adiposity and the polycystic ovary syndrome.
    Escobar-Morreale HF; San Millán JL
    Trends Endocrinol Metab; 2007 Sep; 18(7):266-72. PubMed ID: 17693095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Insulin sensitizers in the treatment of polycystic ovary].
    Ortiz Núñez DA; Hernández Marín I; Ayala AR
    Ginecol Obstet Mex; 2005 Jun; 73(6):315-27. PubMed ID: 16309038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Insulin resistance in patients with polycystic ovary syndrome].
    Wu J; Zhou S; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1999 Nov; 34(11):698-701. PubMed ID: 11479952
    [No Abstract]   [Full Text] [Related]  

  • 11. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk in women with polycystic ovary syndrome.
    Orio F; Palomba S; Colao A
    Fertil Steril; 2006 Jul; 86 Suppl 1():S20-1. PubMed ID: 16798279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in women with polycystic ovary syndrome.
    Essah PA; Nestler JE
    Fertil Steril; 2006 Jul; 86 Suppl 1():S18-9. PubMed ID: 16798277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metformin for the treatment of polycystic ovary syndrome].
    Pekhlivanov B; Mitkov M
    Akush Ginekol (Sofiia); 2005; 44(4):37-41. PubMed ID: 16028378
    [No Abstract]   [Full Text] [Related]  

  • 15. Low birth weight and later development of insulin resistance and biochemical/clinical features of polycystic ovary syndrome.
    Pandolfi C; Zugaro A; Lattanzio F; Necozione S; Barbonetti A; Colangeli MS; Francavilla S; Francavilla F
    Metabolism; 2008 Jul; 57(7):999-1004. PubMed ID: 18555843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S69-73. PubMed ID: 19007650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
    Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiometabolic features of polycystic ovary syndrome.
    Hoffman LK; Ehrmann DA
    Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fertility in polycystic ovary syndrome.
    Patel SM; Nestler JE
    Endocrinol Metab Clin North Am; 2006 Mar; 35(1):137-55, vii. PubMed ID: 16310646
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.